Future and Trends in Immunity-Related Research in Japan, the U.S., and the U.K.
- Research and Future Directions in 2000-2023 -
##article.authors##
-
Naruaki Ogasawara
Editorial Department, The Japanese Society of Internal Medicine (JSIM)
https://orcid.org/0000-0003-0437-2824
https://researchmap.jp/nogasawara
DOI:
https://doi.org/10.51094/jxiv.778Keywords:
Academic Information, Academic Distribution, Academic Journals, Journal, Academic Publishing, Analysis of Published Articles, Research Trends, Internal Medicine, Immunological Diseases, Autoimmune Diseases, Inflammatory Reaction, Inflammatory Diseases, Research Tendency, Research Comparison, International Comparison, MedicineAbstract
In this study, research trends in autoimmune diseases in Japan, the U.S., and the U.K. were investigated based on the number of articles published in major leading journals, and a detailed examination of research increase/decrease trends was conducted, revealing changes and characteristics of research activities in each nation. While research on Rheumatoid Arthritis in each nation shows a decreasing trend after 2018, research on Myasthenia Gravis shows an increasing trend after 2019. In addition, it was found that Japan leads the world in research on IgG4-related diseases, Behcet's disease, and Autoimmune Pancreatitis. The results of this study are reported here because they provide important guidelines for future research directions in Autoimmune Diseases by clarifying research differences and commonalities between Japan and other countries.
Conflicts of Interest Disclosure
No potential Conflicts of Interest were disclosed.Downloads *Displays the aggregated results up to the previous day.
References
小笠原功明. Internal Medicine誌における主要研究テーマ - 直近10年間の論文タイトルのテキストマイニング手法による分析 -. 2024. JST Preprint Server Jxiv. https://jxiv.jst.go.jp/index.php/jxiv/preprint/view/673
Kallinich, T. Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers. Mol Cell Pediatr 11, 5 .2024
Balogh L, Oláh K, Sánta S, Majerhoffer N, Németh T. Novel and potential future therapeutic options in systemic autoimmune diseases. Front Immunol. 2024 Mar 15;15:1249500. doi: 10.3389/fimmu.2024.1249500. PMID: 38558805; PMCID: PMC10978744.
Patrizio Lancellotti, Patrick Marechal, Nathalie Donis, Cécile Oury, Inflammation, cardiovascular disease, and cancer: a common link with far-reaching implications, European Heart Journal, Volume 40, Issue 48, 21 December 2019, Pages 3910–3912, https://doi.org/10.1093/eurheartj/ehz645
Gallucci G, Turazza FM, Inno A, Canale ML, Silvestris N, Farì R, Navazio A, Pinto C, Tarantini L. Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside-Part 1. Int J Mol Sci. 2024 Apr 11;25(8):4232. doi: 10.3390/ijms25084232. PMID: 38673815; PMCID: PMC11049833.
塚原富士子, 丸義朗. 炎症性疾患 (6）炎症とがん.2020. 東女医大誌 90(6): 119-125, 2020.12.
Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, Mason J, Sattar N, McMurray JJV, McInnes IB, Khunti K, Cambridge G. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023 Jun 3;401(10391):1878-1890, 2023
National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. https://doi.org/10.17226/26554.
The National Stem Cell Foundation: Glossary.
Term / Autoimmune Disease.
https://nationalstemcellfoundation.org/glossary/autoimmune-disease/
Tian Y, Shen Q, Peng S, Meng L, Fang R, Xiong A, Li S, Yang Y, Chang W, Ni J, Zhu W. Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysis. Front Neurol. 2023 Dec 28;14:1320344. doi: 10.3389/fneur.2023.1320344. PMID: 38213833; PMCID: PMC10782526.
Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Invest. 2024 Jun 17;134(12):e179742. doi: 10.1172/JCI179742. PMCID: PMC11178544.
Hisanori Umehara, Kazuichi Okazaki, Shigeyuki Kawa, Hiroki Takahashi, Hiroshi Goto, Shoko Matsui, Nobukazu Ishizaka, Takashi Akamizu, Yasuharu Sato, Mitsuhiro Kawano, the Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan., The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD, Modern Rheumatology, Volume 31, Issue 3, 4 May 2021, Pages 529–533& Michael
Downloads
Posted
Submitted: 2024-06-26 04:25:11 UTC
Published: 2024-06-28 10:43:39 UTC
License
Copyright (c) 2024
Naruaki Ogasawara
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
